Procedure Volume Patient Data Patient Conditions Reviews General Payments Back to Top

Home > OK Providers

Dr. Jennifer L. Holter-Chakrabarty, MD

Accepting New Patients

(No ratings)

Specializes in: Adult Oncology and Adult Hematology

University of Oklahoma College of Medicine (1999)

800 Northeast 10th Street
Oklahoma City, OK 73104

(405) 271-8299

Dr. Jennifer L. Holter-Chakrabarty, MD is an oncologist in Oklahoma City, OK specializing in adult oncology and adult hematology. She graduated from University of Oklahoma College of Medicine in 1999 and has 25 years of experience. Dr. Jennifer L. Holter-Chakrabarty, MD is affiliated with OU Health, University of Oklahoma Medicine (OU Medicine) and OU HEALTH PARTNERS INC.

Office Locations

Address:

800 Northeast 10th Street
Oklahoma City, OK 73104

In The News

“It was August 2020 when this choice was made, Nicholson was approached with a study led by Professor of Medicine and oncologist Dr. Jennifer Holter-Chakrabarty.”—"Multiple Oklahoma agencies partner for clinical trial involving home-based blood transfusions", Yahoo News, April 2022

biological response modifier (BRM) therapy	123
chemotherapy	123
doctor visit	199
hospital care	204
inpatient care	204
minimally invasive procedures	142
port flush	17

**Gender**
Male	119
Female	190

**Ethnicity**
Non-Hispanic White	246
Black	32
Hispanic	0
Asian	0
Other	0
Native American	19

**Age**
From 65 to 74	150
From 75 to 84	0
85 and over	0
Less than 65	92

Hypertension	64
High Cholesterol	38
Stroke	0
Ischemic Heart Disease	32
Depression	27
Chronic Kidney Disease	29
Asthma	9
Osteoperosis	8
Atrial Fibrilation	4
Heart Failure	17
Chronic Obstructive Pulmonary Disease	19
Diabetes	28
Dementia	6
Cancer	26

biological response modifier (BRM) therapy	367
chemotherapy	367
doctor visit	171
hospital care	271
inpatient care	271
minimally invasive procedures	405
port flush	48
preventive care	15
vaccines	15

**Gender**
Male	152
Female	283

**Ethnicity**
Non-Hispanic White	342
Black	52
Hispanic	0
Asian	0
Other	0
Native American	22

**Age**
From 65 to 74	210
From 75 to 84	100
85 and over	17
Less than 65	108

Hypertension	65
High Cholesterol	35
Stroke	6
Ischemic Heart Disease	31
Depression	24
Chronic Kidney Disease	30
Asthma	11
Osteoperosis	7
Atrial Fibrilation	6
Heart Failure	20
Chronic Obstructive Pulmonary Disease	17
Diabetes	28
Dementia	5
Cancer	32

biological response modifier (BRM) therapy	245
chemotherapy	245
doctor visit	204
hospital care	147
inpatient care	147
minimally invasive procedures	262
port flush	60

**Gender**
Male	254
Female	500

**Ethnicity**
Non-Hispanic White	590
Black	90
Hispanic	0
Asian	0
Other	0
Native American	36

**Age**
From 65 to 74	366
From 75 to 84	186
85 and over	30
Less than 65	172

Hypertension	65
High Cholesterol	36
Stroke	7
Ischemic Heart Disease	30
Depression	28
Chronic Kidney Disease	33
Asthma	14
Osteoperosis	8
Atrial Fibrilation	8
Heart Failure	23
Chronic Obstructive Pulmonary Disease	19
Diabetes	25
Dementia	5
Cancer	30

biological response modifier (BRM) therapy	64
chemotherapy	64
doctor visit	167
minimally invasive procedures	64
port flush	10

**Gender**
Male	83
Female	149

**Ethnicity**
Non-Hispanic White	177
Black	30
Hispanic	0
Asian	0
Other	0
Native American	13

**Age**
From 65 to 74	117
From 75 to 84	0
85 and over	0
Less than 65	61

Hypertension	59
High Cholesterol	33
Stroke	5
Ischemic Heart Disease	26
Depression	27
Chronic Kidney Disease	39
Asthma	21
Osteoperosis	6
Atrial Fibrilation	6
Heart Failure	17
Chronic Obstructive Pulmonary Disease	19
Diabetes	25
Dementia	9
Cancer	27

biological response modifier (BRM) therapy	136
chemotherapy	136
doctor visit	148
hospital care	89
inpatient care	89
minimally invasive procedures	121
port flush	22

**Gender**
Male	127
Female	198

**Ethnicity**
Non-Hispanic White	260
Black	31
Hispanic	0
Asian	0
Other	0
Native American	22

**Age**
From 65 to 74	172
From 75 to 84	81
85 and over	11
Less than 65	61

Hypertension	69
High Cholesterol	43
Stroke	4
Ischemic Heart Disease	27
Depression	26
Chronic Kidney Disease	38
Asthma	6
Osteoperosis	9
Atrial Fibrilation	8
Heart Failure	19
Chronic Obstructive Pulmonary Disease	18
Diabetes	29
Dementia	5
Cancer	33

biological response modifier (BRM) therapy	38
chemotherapy	38
doctor visit	183
minimally invasive procedures	59

**Gender**
Male	84
Female	91

**Ethnicity**
Non-Hispanic White	131
Black	19
Hispanic	0
Asian	0
Other	0
Native American	12

**Age**
From 65 to 74	100
From 75 to 84	32
85 and over	12
Less than 65	31

Hypertension	67
High Cholesterol	45
Stroke	6
Ischemic Heart Disease	30
Depression	33
Chronic Kidney Disease	45
Asthma	11
Osteoperosis	9
Atrial Fibrilation	10
Heart Failure	25
Chronic Obstructive Pulmonary Disease	14
Diabetes	29
Dementia	9
Cancer	25

doctor visit	137
hospital care	145
inpatient care	145

**Gender**
Male	57
Female	51

**Ethnicity**
Non-Hispanic White	82
Black	12
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	64
From 75 to 84	21
85 and over	0
Less than 65	0

Hypertension	72
High Cholesterol	51
Stroke	0
Ischemic Heart Disease	42
Depression	39
Chronic Kidney Disease	50
Asthma	0
Osteoperosis	0
Atrial Fibrilation	0
Heart Failure	22
Chronic Obstructive Pulmonary Disease	16
Diabetes	27
Dementia	0
Cancer	18

doctor visit	87
hospital care	153
inpatient care	153

**Gender**
Male	49
Female	39

**Ethnicity**
Non-Hispanic White	71
Black	0
Hispanic	0
Asian	0
Other	0
Native American	0

**Age**
From 65 to 74	48
From 75 to 84	21
85 and over	0
Less than 65	0

Hypertension	68
High Cholesterol	53
Stroke	0
Ischemic Heart Disease	45
Depression	44
Chronic Kidney Disease	57
Asthma	0
Osteoperosis	15
Atrial Fibrilation	0
Heart Failure	24
Chronic Obstructive Pulmonary Disease	18
Diabetes	35
Dementia	0
Cancer	22

doctor visit	256
hospital care	471
inpatient care	471

Average Medicare Procedure Volume From 2013 - 2021

Volume of procedures performed by Dr. Jennifer L. Holter-Chakrabarty, MD for Medicare patients.

The highest averages for the top procedures that Dr. Jennifer L. Holter-Chakrabarty, MD treated as an oncologist in Oklahoma City, OK were hospital care, inpatient care, minimally invasive procedures and chemotherapy.

biological response modifier (BRM) therapy	163
chemotherapy	163
doctor visit	173
hospital care	211
inpatient care	211
minimally invasive procedures	176
preventive care	15
vaccines	15

Average Medicare Patient Data From 2013 - 2021

Information about Medicare patients treated by Dr. Jennifer L. Holter-Chakrabarty, MD.

**Gender**
Male	92
Female	150

**Ethnicity**
Black / African American	26
Asian / Pacific Islander	0
Non-Hispanic White	189
Native American / Alaskan Native	12
Hispanic	0
Other	0

**Age**
75 to 84	44
85 and over	7
Less than 65	52
65 to 74	122

Average of Total of Conditions of Medicare patients treated by Dr. Jennifer L. Holter-Chakrabarty, MD From 2013 - 2021

The highest averages of the most common conditions of Medicare patients that Dr. Jennifer L. Holter-Chakrabarty, MD treated were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.

Hypertension	52
High Cholesterol	33
Stroke	2
Ischemic Heart Disease	26
Depression	24
Chronic Kidney Disease	32
Asthma	7
Osteoporosis	6
Heart Failure	16
Chronic Obstructive Pulmonary Disease	14
Diabetes	22
Atrial Fibrillation	4
Cancer	21
Dementia	3

Education & Training

Dr. Jennifer L. Holter-Chakrabarty, MD graduated from University of Oklahoma College of Medicine in 1999. She has a state license in Oklahoma.

Medical School: University of Oklahoma College of Medicine (1999)

Licensed In: Oklahoma

Affiliations & Hospitals

Dr. Jennifer L. Holter-Chakrabarty, MD is associated with these hospitals and organizations:

OU Health

University of Oklahoma Medicine (OU Medicine)

OU HEALTH PARTNERS INC

Ratings & Reviews

Dr. Jennifer L. Holter-Chakrabarty, MD does not have any reviews yet, be the first to leave a review of Dr. Jennifer L. Holter-Chakrabarty, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Jennifer L. Holter-Chakrabarty, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Millennium Pharmaceuticals, Inc.	$117 VELCADE $117
Genentech USA, Inc.	$45 Gazyva $45
Novartis Pharmaceuticals Corporation	$31 KYMRIAH $31
Siemens Medical Solutions USA, Inc.	$26 $26
RECORDATI_RARE_DISEASES_INC.	$24 Sylvant $24
Other	$125 Yescarta $20	IMBRUVICA $20	Kyprolis $18	Non-Covered Product $15	SOLIRIS $14	Other $39

**Types of Payments**
Education	$197
Food and Beverage	$172

Research Payments

Dr. Jennifer L. Holter-Chakrabarty, MD has received 14 research payments totaling $113,688.

Biography

Dr. Jennifer Holter-Chakrabarty is an adult hematology and adult oncology specialist in Oklahoma City, OK. She is professionally affiliated with OU Health. She welcomes new patients at her office inOklahoma City, OK as reported by Doctor.com. Dr. Holter-Chakrabarty studied medicine at the University of Oklahoma College of Medicine.